Search research articles
Contact Us
Filters
Showing results (311-320 of 516) with videos related to
Page
of 52
Sort By:
European Journal of Haematology
|
April 4, 2019
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies
Meletios A Dimopoulos, Jacob P Laubach, Maria Asunción Echeveste Gutierrez, et al.
Blood Cancer Journal
|
June 29, 2022
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
Shaji Kumar, Lawrence Baizer, Natalie S Callander, et al.
Leukemia
|
May 16, 2020
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Joseph Mikhael, Joshua Richter, Ravi Vij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2022
A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma
Anita D'Souza, Nina Shah, Cesar Rodriguez, et al.
Blood
|
September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome
Anita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
Haematologica
|
August 23, 2023
Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma
Paul G Richardson, Brian G Durie, Laura Rosiñol, et al.
American Journal of Hematology
|
June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)
Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Blood
|
December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasm
Wee J Chng, Greg J Ahmann, Kim Henderson, et al.
Bone Marrow Transplantation
|
June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis
Nadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
Blood
|
August 28, 2010
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
Shaji Kumar, Angela Dispenzieri, Jerry A Katzmann, et al.
Page
of 52
Search research articles
Search
Showing results (311-320 of 516) with videos related to
Sort By:
Page
of 52
European Journal of Haematology
|
April 4, 2019
Ixazomib maintenance therapy in newly diagnosed multiple myeloma: An integrated analysis of four phase I/II studies
Meletios A Dimopoulos, Jacob P Laubach, Maria Asunción Echeveste Gutierrez, et al.
Blood Cancer Journal
|
June 29, 2022
Gaps and opportunities in the treatment of relapsed-refractory multiple myeloma: Consensus recommendations of the NCI Multiple Myeloma Steering Committee
Shaji Kumar, Lawrence Baizer, Natalie S Callander, et al.
Leukemia
|
May 16, 2020
A dose-finding Phase 2 study of single agent isatuximab (anti-CD38 mAb) in relapsed/refractory multiple myeloma
Joseph Mikhael, Joshua Richter, Ravi Vij, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 27, 2022
A Phase I First-in-Human Study of ABBV-383, a B-Cell Maturation Antigen × CD3 Bispecific T-Cell Redirecting Antibody, in Patients With Relapsed/Refractory Multiple Myeloma
Anita D'Souza, Nina Shah, Cesar Rodriguez, et al.
Blood
|
September 2, 2011
The utility of plasma vascular endothelial growth factor levels in the diagnosis and follow-up of patients with POEMS syndrome
Anita D'Souza, Suzanne R Hayman, Francis Buadi, et al.
Haematologica
|
August 23, 2023
Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma
Paul G Richardson, Brian G Durie, Laura Rosiñol, et al.
American Journal of Hematology
|
June 19, 2023
A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL)
Alissa Visram, Suzanne R Hayman, Angela Dispenzieri, et al.
Blood
|
December 24, 2005
Clinical implication of centrosome amplification in plasma cell neoplasm
Wee J Chng, Greg J Ahmann, Kim Henderson, et al.
Bone Marrow Transplantation
|
June 11, 2020
Outcomes with early vs. deferred stem cell transplantation in light chain amyloidosis
Nadine Abdallah, Surbhi Sidana, Angela Dispenzieri, et al.
Blood
|
August 28, 2010
Serum immunoglobulin free light-chain measurement in primary amyloidosis: prognostic value and correlations with clinical features
Shaji Kumar, Angela Dispenzieri, Jerry A Katzmann, et al.
Page
of 52